Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer

Clinical trial NCT06871527 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06871527
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastric (Stomach) Cancer Gastric Adenocarcinoma Fruquintinib PD-1 Inhibitor Tislelizumab GEJ Adenocarcinoma

Start date: 2025-03-01
Primary completion: 2028-03-30
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.